Your browser doesn't support javascript.
loading
The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
Gharagozloo, Marjan; Galleguillos, Danny; Jank, Larissa; Sotirchos, Elias S; Smith, Matthew D; Garton, Thomas; Kumar, Swati; Hussein, Omar; Potluri, Saahith; Taylor, Michelle; Siu, Catherine; Mace, Jackson W; Dawson, Ted; Dawson, Valina L; Lee, Seulki; Calabresi, Peter A.
Afiliação
  • Gharagozloo M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. mgharag1@jh.edu.
  • Galleguillos D; Division of Neuroimmunology and Neurological Infections, Johns Hopkins Hospital, Pathology Building 509, 600 N. Wolfe St, Baltimore, MD, 21287, USA. mgharag1@jh.edu.
  • Jank L; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Sotirchos ES; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Smith MD; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Garton T; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Kumar S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Hussein O; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Potluri S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Taylor M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Siu C; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Mace JW; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Dawson T; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Dawson VL; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Lee S; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Calabresi PA; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Neurotherapeutics ; 20(4): 1229-1240, 2023 07.
Article em En | MEDLINE | ID: mdl-37296356

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Remielinização / Esclerose Múltipla Limite: Animals Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças Desmielinizantes / Remielinização / Esclerose Múltipla Limite: Animals Idioma: En Revista: Neurotherapeutics Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos